Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Touyun Tech Group ( (HK:1332) ) has shared an announcement.
Touyun Biotech Group Limited has announced a board meeting scheduled for August 22, 2025, to approve the interim financial results for the first half of the year and discuss the potential payment of an interim dividend. This meeting is significant as it may impact the company’s financial strategy and shareholder returns, reflecting its operational performance and future financial planning.
More about China Touyun Tech Group
Touyun Biotech Group Limited operates in the biotechnology industry, focusing on innovative biotech solutions and products. The company is incorporated in Bermuda and listed on the Hong Kong Stock Exchange, indicating its international market presence and focus.
Average Trading Volume: 617,604
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$272.2M
For a thorough assessment of 1332 stock, go to TipRanks’ Stock Analysis page.